Neuroscience
Posttraumatic Stress Disorder
95%
Nuclear Magnetic Resonance Spectroscopy
60%
Gray Matter Volume
50%
Functional Connectivity
43%
Placebo
43%
Depression
42%
Gamma-Aminobutyric Acid
40%
Brain Network
39%
Magnetic Resonance Imaging
38%
Diabetes Mellitus Type 1
36%
DNA Polymorphism
34%
Blood Plasma
33%
Methamphetamine Dependence
32%
Diabetes Mellitus
32%
Amygdala
32%
Panic Disorder
31%
Major Depressive Disorder
31%
Prefrontal Cortex
30%
Anterior Cingulate Cortex
29%
Bipolar Disorder
27%
Cerebrovascular Accident
25%
Cytidine
22%
Transcranial Direct Current Stimulation
22%
Voxel-Based Morphometry
22%
Cognitive Disorders
22%
Brain Imaging
21%
Sleep Quality
21%
Executive Function
20%
Default Mode Network
20%
Gray Matter
20%
Dorsolateral Prefrontal Cortex
19%
Working Memory
19%
Addiction
18%
Randomized Controlled Trial
18%
Lateral Ventricle
18%
Ghrelin
18%
Bipolar Depression
18%
Spectroscopic Magnetic Resonance Imaging
18%
Prepulse Inhibition
18%
Startle Response
18%
Auditory Brainstem Response
18%
Trait Anxiety
18%
Mirtazapine
18%
Alzheimer's Disease
17%
Glutamic Acid
17%
Magnetic Resonance Imaging
17%
Antidepressant
16%
Antioxidant
16%
Alcohol Abuse
15%
Diffusion Tensor Imaging
15%
Choline
15%
Metabolic Pathway
14%
Brain-Derived Neurotrophic Factor
14%
Synaptic Transmission
13%
Dopamine Receptor
13%
Mood Disorder
13%
Catastrophizing
13%
Transcranial Magnetic Stimulation
13%
Sleep Disorder
13%
Hippocampus
13%
Sleep Time
13%
Hamilton Rating Scale for Depression
13%
N-Acetylaspartic Acid
13%
Precuneus
13%
Dopaminergic
12%
Glutamine
12%
Oxidative Stress
12%
Frontal Lobe
12%
Basal Ganglia
11%
Traumatic Brain Injury
11%
Neurotrauma
11%
Hyperbaric Medicine
10%
Bipolar I Disorder
10%
Thalamus
10%
Beck Depression Inventory
10%
Neurological Disorder
9%
Fk 506 Binding Protein
9%
Dopamine Receptor D2
9%
Individual Differences
9%
Dopamine Receptor D1
9%
Opioid Dependence
9%
Septum Pellucidum
9%
Depression
9%
Risperidone
9%
Cytokine Production
9%
Hypoxia-Inducible Factors
9%
Aquaporin 4
9%
Lovastatin
9%
Hypoxia Inducible Factor 1
9%
Electroencephalogram
9%
Treatment of Depression
9%
Interferon Gamma
9%
Nerve Growth Factor
9%
Manganese Superoxide Dismutase
9%
Gyrification
9%
Tetrahydropyridine
9%
Brain Plasticity
9%
Interleukin 12
9%
Interleukin 10
9%
Pervasive Developmental Disorder
9%
Psychology
Posttraumatic Stress Disorder
100%
Emotional Distress
27%
Alcohol Use Disorder
27%
Magnetic Resonance Spectroscopy
26%
Transcranial Direct Current Stimulation
22%
Depression
20%
Neuroimaging
19%
Traumatic Brain Injury
19%
Clinical Interview
19%
Cerebral Blood Flow
18%
Bipolar Depression
18%
Dorsolateral Prefrontal Cortex
17%
Amygdala
16%
Neuroimaging Study
16%
Rating Scale
16%
Psychiatric Disorder
15%
Executive Function
15%
Human Brain
14%
Functional Connectivity
12%
Insula
11%
Prefrontal Cortex
11%
Hippocampus
10%
Inhibition
10%
Beck Depression Inventory
10%
Self-Transcendence
10%
Cognitive Performance
10%
Neurological Disorder
9%
Intraclass Correlation
9%
Self-Report Questionnaire
9%
Psychological Distress
9%
Stroke Patient
9%
Regional Cerebral Blood Flow
9%
Alzheimer's Disease
9%
Hemiplegia
9%
Addictive Behavior
9%
Factor Analysis
9%
Human Cognition
9%
Parahippocampus
9%
Psychological Resilience
9%
State Trait Anxiety Inventory
9%
Novelty Seeking
9%
Pervasive Developmental Disorder
9%
Individual Differences
9%
Positron-Emission Tomography
8%
Convergent Validity
8%
Traumatic Event
6%
Network System
6%
Psychology
6%
Thalamus
5%
Internet Addiction
5%
Neurobiological Mechanism
5%
Early Intervention
5%
Gaming
5%
Pharmacology, Toxicology and Pharmaceutical Science
Tolerability
20%
Hangover
18%
Ethanol
18%
Paroxetine
18%
Posttraumatic Stress Disorder
13%
Major Depression
13%
Non Insulin Dependent Diabetes Mellitus
13%
Placebo
13%
Disease
13%
Sodium Valproate
10%
Antidepressant
10%
Injury
10%
Normal Human
9%
Cytokine
9%
Adverse Event
9%
Dopamine Receptor
9%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
9%
Drug Dependence
9%
Sleep Disorder
9%
Dopamine Receptor Stimulating Agent
9%
Bipolar Depression
9%
Insulin Resistance
9%
Fluoxetine
9%
Neutropenia
9%
Aripiprazole
9%
Tic
9%
Quetiapine
9%
Generalized Anxiety Disorder
9%
Mirtazapine
9%
Procyanidin
9%
Phthalic Acid
9%
Methanol
9%
Mevinolin
9%
Narcolepsy
9%
Venlafaxine
9%
Procollagen
9%
Cytidine
9%
Spinal Cord Injury
9%
Brain Derived Neurotrophic Factor
7%
Traumatic Brain Injury
7%
Obesity
7%
Selective Serotonin Reuptake Inhibitor
6%
Controlled Clinical Trial
5%
DSM-IV
5%
Inflammation
5%